Insider Trading March 6, 2026 11:40 PM

Amalgamated Financial EVP Disposes of $19,478 in Shares Under 10b5-1 Plan

Tyrone Graham sells 501 shares as company posts Q4 2025 revenue ahead of estimates while EPS meets expectations

By Caleb Monroe AMAL

Tyrone Graham, Executive Vice President and Chief Human Resources Officer at Amalgamated Financial Corp (NASDAQ: AMAL), sold 501 shares on March 4, 2026, under a pre-established Rule 10b5-1 trading plan. The transaction totaled $19,478 at $38.88 per share. Following the sale Graham retained 15,538.56 shares. Separately, Amalgamated Financial reported Q4 2025 results with EPS of $0.91 in line with expectations and revenue of $87.91 million, a 2.98% surprise above forecasts.

Amalgamated Financial EVP Disposes of $19,478 in Shares Under 10b5-1 Plan
AMAL

Key Points

  • An Amalgamated Financial executive sold 501 shares on March 4, 2026, under a Rule 10b5-1 plan, realizing $19,478 at $38.88 per share.
  • After the sale, the executive retains 15,538.56 shares; AMAL traded at $37.80 and has gained 32% over six months, with an 18.5% year-to-date rise according to InvestingPro.
  • Amalgamated Financial's Q4 2025 results showed EPS of $0.91 in line with expectations and revenue of $87.91 million, a 2.98% beat versus forecasts.

Tyrone Graham, who serves as Executive Vice President and Chief Human Resources Officer at Amalgamated Financial Corporation (NASDAQ: AMAL), executed a sale of company common stock on March 4, 2026, according to a Form 4 filing with the Securities and Exchange Commission.

The filing shows Graham sold 501 shares at $38.88 per share, producing a total transaction value of $19,478. The sale was carried out under a Rule 10b5-1 trading plan that Graham adopted on December 4, 2024. After the transfer, Graham directly holds 15,538.56 shares of Amalgamated Financial Corp.

At the time of reporting the stock traded at $37.80, modestly below the per-share price realized in Graham's sale. Over the prior six months the shares have delivered a 32% return, and InvestingPro analysis cited in the filing characterizes AMAL as appearing undervalued at current levels. The security has also recorded an 18.5% gain year-to-date.

In corporate results released for the quarter, Amalgamated Financial reported fourth-quarter 2025 earnings per share of $0.91, a figure that matched analyst expectations. Revenue for the quarter came in at $87.91 million, which exceeded forecasts by 2.98%.

The combination of a prearranged insider sale, recent market performance, and quarterly results are the primary data points contained in the company filings and reporting. The Form 4 discloses the mechanics of the trade, including the 10b5-1 plan governing the transaction, and the company earnings release provides the EPS and revenue figures noted above.


Contextual facts

  • The sale involved 501 shares at $38.88 per share, totaling $19,478.
  • Post-sale direct ownership by Graham is 15,538.56 shares.
  • The sale was executed under a Rule 10b5-1 trading plan adopted on December 4, 2024.
  • AMAL stock traded at $37.80 at the time of this report, with a six-month return of 32% and an 18.5% year-to-date gain per InvestingPro analysis.
  • Q4 2025 results: EPS $0.91 (in line with expectations); revenue $87.91 million (2.98% above forecasts).

This report is based on the Form 4 filing and the company's quarter-end disclosure. It confines itself to the specific transactions and reported financial figures documented in those filings.

Risks

  • Market price at reporting was below the sale price, indicating short-term price variance that affects market value of holdings - relevant to financials and equity markets.
  • The executive sale occurred under a Rule 10b5-1 trading plan, which limits conclusions about intent since trades are prearranged - relevant to corporate governance and market signaling.
  • Earnings per share matched expectations while revenue exceeded forecasts by 2.98%, leaving room for investor focus on future quarters for confirmation of trend - relevant to banking and financial services sector performance.

More from Insider Trading

Texas Instruments Executive Executes $1.46 Million Stock Sale Amid Recent Price Surge May 12, 2026 Edwards Lifesciences CEO Executes Multi-Million Dollar Share Sale via Pre-Set Trading Plan May 12, 2026 Covista CFO Executes $1.26 Million Stock Sale via Pre-Scheduled Trading Plan May 12, 2026 Covista Executive Executes Planned Share Sale Amidst Corporate Growth and Financial Restructuring May 12, 2026 Covista Executive Executes $1.22 Million Stock Sale Under Pre-Planned Trading Program May 12, 2026